Brexit uncertainty sees UK patients cut from heart attack drug trial
This article was taken from: https://www.independent.co.uk/news/health/brexit-heart-attack-drug-trial-research-european-medicines-agency-recardio-dutogliptin-a8566426.html By Alex Matthews-KingHealth Correspondent Concern over eligibility of British data post-March 2019 behind decision to pause study in England and Scotland UK patients have been cut from an international clinical trial to test a new heart attack drug because of uncertainties about registering new medicines after Brexit. The drug, dutogliptin, is being tested to…